DG Early-Morning Show

In this episode, I talked to Dr. Nir Barzilai, the founding director of the Institute for Aging Research, on longevity, GLP-1 potentially treating aging, genetics of longevity, Trump's new food pyramid, and staying socially active to be "younger".  --------------------------------------------------------------- Thanks to the sponsors: Audible: Use my link for a 30-day free trial: http://audibletri...

In this episode, I talked to Dr. Alex Zhavoronkov, CEO of Insilico Medicine, about using AI to generate small molecules for future drugs/therapies, pharma superintelligence, automation of drug discovery, China potentially beating US in biotech innovation, aging, and other funny things, like his head transplant video.  --------------------------------------------------------------- Thanks to the sp...

In this episode, I talked to Dr. Alexander Marson, cofounder of Arsenal Biosciences and director of the Gladstone-UCSF Institute of Genomic Immunology. He is one of the pioneers of non-viral T-cell editing and is a serial biotech entrepreneur. We talked about Car T-cell Therapy, using CRISPR to edit T-cells, biotech, and his collaboration with Sean Parker, cofounder of Napster.  ------------------...

In this episode, I talked to Dr. Samuel Stupp, Board of Trustees Professor of Materials Science, Chemistry, and Medicine at Northwestern University. He is one of the pioneers of supramolecular self-assembling materials and is a cofounder of multiple biotech startups, like Amphix Bio, that is working on regenerating spinal cords and tissues using biomaterials.  -------------------------------------...

In this episode, I talked to Dr. Leslie Leinwand, Chief Scientific Officer of the BioFrontiers Institute at the University of Colorado Boulder and serial entrepreneur. In addition to her lab, she is the founder of Myogen, acquired by Gilead Sciences, Myokardia, acquired by Bristol Myers Squibb, and her new startup, Kardigan. We talked about the behind the scenes stories of her different companies...

In this episode, I talked to Dr. Karolina Valente, CEO of Voxcell BioInnovation. Dr. Valente talks about how her company, Voxcell, is trying to revolutionize the drug development process by developing customizable 3D tissue models to test different therapeutics and drugs. We also talked about how AI will affect future drug trials, Vancouver's potential as a biotech hub, improvements needed to stre...

In this episode, I talked to Dr. David Schaffer, director of the Bakar Labs at UC Berkeley and cofounder of publicly-trade biotech caleld 4D Molecular Therapeutics. We talked about different topics from the ethics of gene therapy to stem cell tourism, biotech business, and how Bakar Labs provides an incubator spot for other startups.  ---------------------------------------------------------------...

I got the opportunity to talk to Dr. Liz Kwo, Chief Commercial Officer at Everly Health, Board member of Walmart Mexico, and experienced venture capitalist and angel investor. We talked about running the first online medical group in the US, telehealth, her angel investments, being on the board of several NASDAQ listed companies, remote surgery, Da Vinci robot and minimally invasive surgery, exper...

I got the opportunity to talk to Dr. Jennifer Elisseeff, Morton Goldberg Professor and Director of the Translational Tissue Engineering Center at Johns Hopkins University and experienced entrepreneur. She is currently doing research on tissue engineering, ophthalmology and immunology. Her main focus is now identifying the response of the  immune system to implanted biomaterials and how biomaterial...

I got the opportunity to talk to Michael Langer, a well-known venture capitalist and investor in the biotech and health care industry, who is also the son of Moderna cofounder, Dr. Robert Langer.  We talked about the investments he made, family investments, how to start a VC firm, challenges of the VC firm, and popular biotech trends. --------------------------------------------------- Thanks to t...

I got the opportunity to talk to Dr. Michael Deem, a former bioengineering department chair at Rice, entrepreneur, and experienced venture capitalist. We talked about the similarities and differences between working in academia and industry, his advice for entrepreneurs and startups, experiences as a VC, his former research at Rice, and if Shark Tank may be an accurate reflection of how investing...

I got the opportunity to talk to Dr. Joseph Schlessinger, professor at Yale and cofounder of SUGEN and Plexxikon. We talked about his experience as a captain the Israeli Army during the Six Day War and the Yom Kippur War and how it affected his career as a scientist and entrepreneur. We also talked about the companies he formed and his research on tyrosine kinase.  --------------------------------...

I got the opportunity to talk to Dr. Christina Schmidt, professor at the Universit of Florida and inventor of the Avanca Nerve Graft. We talked about a lot of things from how she adapted to different climates, biomaterials, Avanca Nerve Graft, to licensing IP and entrepreneurship.  --------------------------------------------------- Thanks to the sponsors: Audible: Use my link for a 30-day free tr...

I got the opportunity to talk to Dr. Eric Verdin, CEO of Buck Institute and an accomplished entrepreneur. We also talked about health advice for longevity, the supplement industry, beef between Dr Charles. Brenner and Dr. David Sinclair, Bryan Johnson, and his passion for F1.  --------------------------------------------------- Thanks to the sponsors: Audible: Use my link for a 30-day free trial:...

I got the opportunity to talk to Dr. Peter C. Doherty, the 1996 Nobel Prize winner in Physiology or Medicine. He is an internationally recognized scientist in immunology, and now scientific communication. We also talked about his challenges of earlier research, misinformation regarding climate change, and scientific communication.  --------------------------------------------------- Thanks to the...

I got the opportunity to talk to Dr. Martin Chalfie, 2008 Nobel Prize Winner in Chemistry. He is an internationally recognized scientist in green fluorescence proteins, C elegans, and touch nerve development. We also talked about his challenges of finding a career in his early days.  --------------------------------------- Thanks to the sponsors: Audible: Use my link for a 30-day free trial: http:...

I got the opportunity to talk to Dr. Roozbeh Ghaffari, experienced entrepreneur and CEO of Epicore Biosystems. We talked about his new wearable tech company called Epicore Biosystems that tracks people's sweat levels, Epicore's partnerships with Gatorade and global athletes, like Lionel Messi, Serena Williams, and Jayson Tatum, and entrepreneurial advice. Thanks to the sponsors: Audible: Use my li...

I got the opportunity to talk to Dr. Charles Brenner, an expert in aging research and Alfred E Mann Family Foundation Chair of the Department of Diabetes & Cancer Metabolism at the Beckman Research Institute of the City of Hope National Medical Center. We talked about if eternality and reverse aging is possible and how a Harvard scientist misled investors and companies and scammed people about...

I got the opportunity to talk to Dr. Robert Tjian, former President of the Howard Hughes Medical Institute, about how Amygen acquired his startup, Tularik, for more than a billion dollars, venture capitalist experience, and transcription factors. Thanks to the sponsors: Audible: Use my link for a 30-day free trial: http://audibletrial.com/diamondgoat Newsly: https://newsly.me promo code to receive...

I got the opportunity to talk to Dr. Charles M. Rice, Rockefeller University professor and 2020 Nobel Prize in Physiology or Medicine, about Hepatitis C and B, Covid-19 virus research, RNA viruses, Yellow Fever Virus, and scientific communication. Thanks to the sponsors: Audible: Use my link for a 30-day free trial: http://audibletrial.com/diamondgoat Newsly: ⁠https://newsly.me⁠ promo code to rece...

Dr. Ali Khademhosseini, CEO of Terasaki Institute and Omeat, talks about advances in 3D bioprinting, organ-on-chip systems to lower drug development costs, entrepreneurship, Terasaki incubator, and how his cultured meat startup, Omeat, is going to revolutionize the food industry. Thanks to the sponsors: Audible: Use my link for a 30-day free trial: http://audibletrial.com/diamondgoat Newsly: https...

I got the opportunity to talk to Dr. Kathryn Whitehead, professor of Carnegie Mellon. We talked about a range of topics from her lipid nanoparticle drug delivery methods in Covid-19 vaccine and Covid-19 side effects on young people (myocarditis) to genetically engineered breast milk and oral delivery of drugs. ----------------------------------------- Thanks to the sponsors: Audible: Use my link f...

I got the opportunity to talk to Dr. David Relman, the Thomas C. and Joan M. Merigan Professor in Medicine, and in Microbiology & Immunology at the Stanford University School of Medicine. We talked about a range of topics from his lactose intolerance research and investigating if probiotics can help your gut to biosecurity concerns and trying to come out of his dad's shadow. ------------------...

I got the opportunity to speak with Dr. Shiladitya DasSarma, a professor at the University of Maryland Baltimore. We talked about his hypothesis, Purple Earth Hypothesis, potential life on Mars, halophilic microbes living in Antarctica, and more. ----------------------------------------- Thanks to the sponsors: Audible: Use my link for a 30-day free trial: http://audibletrial.com/diamondgoat Newsl...

I got the opportunity to speak with Dr. Leroy Hood, the cofounder of the Institute for Systems Biology. He is also instrumental in founding Amgen, one of the world's largest independent biotechnology companies. We got to talk about P4 medicine, AI's future role in biotech, and tips for entrepreneurs. ----------------------------------------- Thanks to the sponsors: Audible: Use my link for a 30-da...